CGEM vs PG · $830.3M cap vs P/E 25, rev $84.28B
Cullinan Oncology LLC (CGEM) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CGEM currently screens at market cap $830.3M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CGEM and PG stock pages for the full models.
Not investment advice.